in patients with sub-optimal echocardiosrams. In addition, the use of contrast echocardiosraphy in clinical practice allows blood-flow assessment, identification of 8eornetric distortions (such as an aneurysrn or a pseudoaneurysrn), and differentiation of various mass formations (such as thrornbus, tumor, or sirnp[e trabecu[ation). Onsoin8 scientific work points to the potential of contrast echocardiosraphy in assessin8 myocardial perfusion and in usin8 contrast asents in therapeutic maneuvers. The use of modern contrast asents in echocardiosraphy can shorten examination time, improve diasnostic accuracy, eliminate unnecessary tests, and tower medical costs. In fact, qualitative or quantitative assessment of cardiac function is difficult to achieve without the improved visualization provided by contrast enhancement.
Introduction
Echocardiographic examination has been the cornerstone of cardiac diagnosis in a variety of cardiovascutar disorders for over two decades. Two-dimensional and Doppler echocardiographic modatities provide vatuabte information on cardiac structures, chamber function and hemodynamic derangements. White considerable strides have been made in refining the resotution and quatity of uttrasound images, poor acoustic windows encountered in patients with obesity, tung disease or unfavorable chest geometry pose a major chaUenge in acquiring diagnostic-quatity images in a sizabte portion of patients. aid in a certain number of patients but cannot be apptied widety because of its invasive nature. The devetopment of uttrasound contrast agents that traverse the putmonary circutation and opacify teft heart chambers has attowed us to overcome the difficutties in obtaining diagnostic data in patients with technicatty sub-optimat acoustic windows I 5.
These agents are smatter than 6 microns and thus are abte to pass through the putmonary capittary bed. Many contain high-motecutar-weight gases such as perfluorocarbon or sutfur hexafluoMde. Optison ® is an agent that consists of perfluoropropane-fitted atbumin microspheres with a mean size of tess than 4 microns. De[inity ® is a tiposomecoated bubbte containing perfluorocarbon gas that has been shown to have a simitar use. SonoVue ® is a phosphotipid-coated, sutphur-hexafluoMdecontaining agent that can be used for cavity opacification as weir as perfusion assessment. Imagent ® is an agent that contains nitrogen and perfluorocarbon gases. Other agents under $4 N.G. Pandian investigation include AI-700 and Bisphere. All these agents can be used for cavity opacification, and some have a strong prospect for myocardial perfusion assessment. White the initia( impetus in engineering transpulmonary contrast agents was the desire to devetop a technique to assess myocardia( perfusion, the widety apptied indication today is opacification of (eft-sided cardiac chambers. Evotving advances point to the strong potentia( of myocardia( contrast echocardiography in the evatuation of perfusion abnormatities in various coronary syndromes. In this article we wit( review the current apptication of contrast echocardiography and its future potential Application in the assessment of ~llobal and re~lional left ventricular function Successful evaluation of global and regional [eft ventricular (W) function requires optimal visualization of endocardial borders. Correct detection of watt-motion abnormatities is important in patients with suspected or established coronary artery disease for diagnostic purposes. It allows identification of coronary artery disease in patients with chest pain. Accurate delineation of the extent of contractite abnormatities in patients with myocardial infarction has prognostic implications. The key sign of coronary artery disease during stress echocardiography is inducible watt-motion abnormality. If interpretation of echocardiographic images is attempted when the chamber borders are it[ defined, both fatse positive and fatse negative errors can frequently occur. Fig. 1 shows the best possibte two-dimensiona( images during systote from the apical window (left-hand panel) in a patient with chest pain. The LV cavity borders are not seen in most parts of the chamber. LV opacification with contrast brings out the borders clearly, aiding in correct interpretation (right-hand panel). Shown in Fig. 2 are images from two patients with apparent apica( dyskinesia ((eft-hand pane(). Contrastenhanced images (right-hand panel) allow one to establish not only that the apex is not dyskinetic, but that in fact it is hyperdynamic. In addition, the apica[ myocardium has increased wall thickness, providing the diagnosis of apical hypertrophic cardiomyopathy. The difficutty in assessing regiona[ wall motion is compounded by increased heart rate and breathing artifacts during stress echocardiography. In an obese patient with poor acoustic windows, contrast administration attowed better visuatization of LV borders and aided in correct interpretation (Fig. 3) . Uttrasound contrast is used in more than 50% of patients undergoing stress echocardiography in many [aboratories.
Indices of gtoba[ LV function have diagnostic, prognostic and therapeutic implications. Without optima[ border visuatization, it is difficutt to evaluate LV function property. The challenge is compounded if quantitative estimates of LV volumes and percentage ejection fraction (%EF) are to be derived. In contemporary cardiology, LV ejection fraction (LVEF) has become the single most important index in ctinica( decision making. Whether LVEF is 50% or tess could be the marker in giving a diagnosis of LV dysfunction or cardiomyopathy in a given patient. Whether the LVEF is tess or more than 40% has imptications regarding the use of pharmacologic agents such as angiotensinconverting-enzyme inhibitors. Whether the LVEF is 35%, or 30%, or tess, coutd inftuence the decision with regard to intracardiac defibrittator placement. Unless the LV endocardia[ borders are crisp, quantitative assessment of LV volumes and EF cannot be performed. Diastolic and systolic images of the LV from a patient with ischemic heart disease are shown in the upper pane[ of Fig. 4 . The information needed for this patient was WEE It is obvious that border tracing for quantitation woutd be impossibte in images of such poor quality. Administration of ultrasound contrast opacified the LV chamber, attowing the operator to perform accurate quantitative analysis. The LVEF in this study was 27%, and this information had imptications in terms of pharmacotogic and etectrica( therapy in this patient. Administration of uttrasound contrast agent has thus greatty increased our abitity to correctty assess regiona( and global LV function, and has decreased the number of errors made in such assessments 1 4.
Application in the assessment of LV 8 e o m e t r y and intracardiac patholosy
If echocardiographic images are of sub-optima( quality, alterations in LV geometry, presence or absence of LV aneurysms, and presence or absence of intracardiac masses such as c(ots and tumors can be missed or misdiagnosed. Fig. 5 displays an LV image from an apical orientation in a young patient with ventricu[ar tachycardia and a history of syncope. The apex was poorly defined in the pre-contrast image. The contrast-enhanced study unmasked a stoat(, well-defined apical diverticulum, an entity associated with life-threatening ventricu[ar arrhythmias. This diagnosis could have been missed if contrast echocardiography had not been performed in this subject. More frequently raised questions however are whether a patient has an LV aneurysm and whether a patient has intracardiac dots. The presence or absence of thrombi in the LV has implications with regard to the use of anticoagulant therapy. It is hard to detect or exclude an apical thrombus if the apex is not we[[ defined, as in the twodimensional echocardiographic image seen at [eft in Fig. 6 . A contrast-enhanced recording (righthand image) in the same patient ted to the correct interpretation that there was no apical thrombus present. The (eft-hand pane[ of Fig. 7 shows two other examples of how difficult it can be to confirm or exclude the presence of a thrombus. On the contrary, the contrast images in the right-hand pane[ clearly expose intracardiac c(ots in both cases.
Detailed investigation of any patho[o~ associated with the heart is aided by contrast echocardiography. Fig. 8 shows images from a patient who had inferior watt ischemic changes on the electrocardiogram. In real-time imaging, the inferior watt was hypokinetic, and there was an area that resembled a possible pseudoaneurysm (top pane[ of Fig. 8 ). Contrast-enhanced imaging an abnormality near the inferior watt (asterisk) that could be mistaken fora pseudoaneurysm, Bottom: contrast images reveal a mass encroaching on the inferior wall, Fig. 7 . Left: non-contrast images from two patients do not display the apex with clarity, Right: contrast enhancement allows recognition of apical dysfunction and thrombi, excluded a pseudoaneurysm, and successfuLLy characterized the abnormality as a mass adjacent to the inferior wall, infittratin g into the myocardium, with lack of perfusion in that region. Further investigations documented that it was a lymphoma (bottom panel of Fig. 8) .
ULtrasound contrast agents are also useful in transesophageal echocardiography (TEE) examinations. TEE is frequently performed to venfy the presence or absence of thrombi in the left atrial appendage (LAA). With its high-resolution images, TEE generally can answer that question. However, thick sludge in the LAA can masquerade as a thrombus in some patients. Contrast administration can aid in differentiating between true organized clot and simply a thick sludge. Two examples Fig, 9 , Left: non-contrast transesophageaL images of Left atrial appendage in two patients; the presence or absence of a clot (arrows) can not be discerned with clarity, Right: contrast images reveal a clear appendage in the first patient and a fiLLing defect in the second patienL are portrayed in Fig. 9 . In the top pane[, a circular echo density raised the question of a thrombus (top left, Fig. 9 ). When contrast was administered (top right), it fiLLed the whole I_AA, delineating the I_AA borders and demonstrating that the echo density noted was an extracardiac structure and that the LAA was free of thrombus. In the bottom example the pre-contrast image raised the suspicion of an LAA clot (bottom left); the contrast-enhanced image displayed a definite filling defect and confirmed the presence of a clot.
Application in the assessment of Doppler recordings
Doppler echocardiography provides important hemodynamic data in the study of valvular disorders, congenital heart defects and ventricular function. In patients with sub-optimal acoustic windows, the Doppler signals can be weak despite proper techniques. In such a setting, contrast agents can be used to enhance the strength of the Doppler signals. In color flow imaging, contrast is useful in augmenting coronary artery flow and carotid artery flow. A more frequent application, however, is in spectral Doppler imaging. In patients with abnormalities such as aortic stenosis, in whom accurate delineation of velocity profile is desired to determine pressure gradients, contrastenhanced Doppler examination can bring out the velocity profile as illustrated in Fig. 10 . Tricuspid regurgitation velocity is an important datum in the determination of pulmonary artery systolic pressure. White agitated saline can be employed to visualize the right heart chambers, this method is not consistently useful in delineating tricuspid regurgitation velocity because of spiky signals due to uncontrolled bubble size and distribution (Fig. 11) . The new-generation contrast agents allow more robust signal enhancement. Pulmonary vein flow velocity recording is of value in the assessment of diastolic LV function and fitting pressures. Pulmonary vein flow can be difficult to record in a certain proportion of patients because of the resolution compromise in the far field when examined from apical imaging windows. Contrast imaging augments flow signals at any depth and is thus useful in the determination of LV diastolic function. 
Application in the assessment of myocardial perfusion
Currentty avaitabte non-invasive methods such as nuclear imaging and stress echocardiography have limitations. Ischemic syndromes are often complex with frequent admixtures of reversible ischemia, acute or otd infarction, myocardiat stunning, and myocardiat hibernation, and these often express themselves as stable or unstable syndromes. There is thus a need for a method that can be used in all clinical circumstances to identify coronary syndromes even before contractile abnormalities evolve, and that can easily be performed at the bedside. Myocardial perfusion imaging utilizing contrast echocardiography has the potential to fulfill this need 5 7. Optimal assessment of the perfusion status requires appropriate imaging modes and examination protocols in various ischemic syndromes. Intentional destruction of the microbubhies with high-power ultrasound and evaluation of the rate of replenishment is an important element in the assessment of myocardial perfusion (Fig. 12) . In the setting of a myocardial infarction, as in a patient with an old or new coronary occlusion, perfusion imaging at rest demonstrates a tack of contrast enhancement in the area devoid of myocardial blood flow white normal regions exhibit increased brightness due to contrast enhancement. White imaging at rest is sufficient in most patients, the use of a vasodilator can further aid in defining normal and abnormal perfusion.
Myocardial contrast echocardiography can be extremely useful for assessing the status of the FiB. 12. Myocardial perfusion imasin8 with transpulmonary contrast. Left: contrast enhancement of the myocardium. Middle: followin8 a hish power ultrasound, immediate destruction of myocardial sisnals is noted. Risht: replenishment of myocardial blood is demonstrated by normal contrast distribution in the myocardium.
FiB. 14. Left: a (arse dyskinetic zone is seen in this systolic apical imase of the left ventricle in a patient with myocardial infarction followin8 reperfusion therapy. Risht: myocardial contrast echocardiosraphy exhibits lack of contrast enhancement in the dyskinetic zone, indicatin8 a lack of reperfusion at the microcirculation level.
FiB. 13. Left: a larse dyskinetic zone is seen in this systolic apical imase of the left ventricle in a patient with myocardial infarction followin8 reperfusion therapy. Risht: myocardial contrast echocardiosraphy exhibits normal contrast enhancement in most of the dyskinetic resion except for a small residual area of necrosis.
microvascuLature and myocardial viability after thromboLytic therapy or coronary ansiopLasty. Normal or near-normal myocardial contrast enhancement in the risk territory implies restored microvascuLar intesrity and saLvased myocardium, or a smaLL residual infarct 7 (FIB. 13). This would be so even if the myocardial resion exhibits contractile abnormalities due to stunnins. On the other hand, a lack of contrast enhancement or a markedly decreased perfusion implies tissue necrosis in most circumstances or depressed microvascuLar function (FIB. 14). The use of myocardial contrast echocardiosraphy in patients undersoin8 recanaLization therapy has dearly demonstrated that recanaLization and restoration of flow in an epicardiaL coronary artery does not equal myocardial reperfusion. Myocardial maLperfusion can be the result of a number of mechanisms operatin8 durin8 the perirecanalization period. Showers of microemboli, formation of microthrombi, microvascuLar spasm, and reperfusion injury caused by oxysen free radicals, neutrophiL pLu88in8 of capiLLaries, and tissue edema could individuaLLy or in combination lead to myocardial malperfusion. Serial myocardial contrast echocardiosraphy yields FiB. 15. Left: perfusion imase at rest in a patient undersoin8 stress echocardiosraphy reveals normal perfusion. Risht: imase at peak stress displays a larse zone of lack of myocardial contrast sisnals, indicatin8 ischemia.
vatuabte physiotosic insishts into the intesrity and behavior of the microvascutature in the risk area and yietds prosnostic data. This information coutd be usefut in formutatin 8 optimat therapy and in exptorin 8 means of improvin 8 myocardial matperfusion. The detection of functionatty sisnificant coronary stenoses requires some form of stress that chattenses coronary vascular reserve. Both exercise stress and pharmaco[osic stress can be eraptoyed. Amon 8 pharmacolosic approaches, dipyridamote and adenosine are commonly employed vasodilators, and dobutamine is a widely used inotropic asent. Dipyridamole and dobutamine are administered as infusions while adenosine is used both as an infusion and in boluses. Some contrast asents are 8iven in boluses, and some as infusions. Perfusion imasin 8 durin 8 pharmacolosic or exercise stress unmasks the coronary reserve and can aid in the recosnition of coronary disease and the resions at risk 5,6 (Fi 8. 15). Dipyridamote perfusion imasin 8 yields a diasnostic accuracy of >80% in the detection of reversible ischemia. The use of adenosine bo(us or infusion yie(ds a diagnostic accuracy of 80-95%, depending on the experience of the investigators. Exercise and dobutamine stress procedures have a(so proven to be re(iab(e. Performing myocardia( contrast echocardiography fo((owing physica( exercise is somewhat of a cha((enge because of the short ischemic time avai(ab(e for acquiring the images. Infusion of the contrast agent, rather than a bo(us administration, makes the exercise more practical Perfusion imaging can be easi(y performed during dobutamine stress. A mu(titude of c(inica( investigations emp(oying various forms of stress during echocardiography have demonstrated that myocardia( contrast echocardiography carries a high diagnostic accuracy in the eva(uation of functiona((y significant CAD.
Intracoronary contrast administration aids in the identification of the appropriate target site in the interventricu(ar septum in patients with hypertrophic obstructive cardiomyopathy undergoing septa( ab(ation with ethano(. During the ab(ation procedure, contrast agent is administered onto the catheter cannu[ating the septa[ perforator artery. The region supp(ied by this vesse( exhibits contrast enhancement. If this is not the portion of the septum that needs to be ab(ated, a different septa[ perforator vesse[ is chosen. In addition, the necrosis produced by ethano[ can be recognized by perfusion imaging a (Fig. 16) .
Contrast echocardiography is also combined with other innovations in cardiovascular ultrasound. Three-dimensiona( echocardiography has become a c(inica( too(, but it suffers from the same reso(ution prob(ems as two-dimensiona( u(trasound in patients with poor acoustic windows. In these settings, contrast agents improve reso(ution of chamber borders and aid in three-dimensiona( quantitation of cardiac chamber vo(ume and function (Fig. 17) .
Conclusion
Contrast echocardiography using the new generation of u(trasound contrast agents has become an important technique in the eva(uation of regiona( and g(oba( LV function, intracardiac patho(ogy, and hemodynamics. Its potentia( in providing information on myocardia( perfusion is high(y promising. Possib(e app(ications in (oca( drug and gene de(ivery are being active(y exp(ored. The optima( practice of echocardiography today is not possib(e without the use of u(trasound contrast agents.
